Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lipid status and linear relationship between total cholesterol and triglycerides in glycogen storage disease type I.

European review for medical and pharmacological sciences - 1 Oct 2020

Zhang Z-J, Yuan Y-H, Ma M-S, Hong Y-H, Sun Z-X, Xu Y-W, Wei M, Qiu Z-Q

Abstract excerpt

OBJECTIVE: Glycogen storage disease type Ia (GSDIa) is a glucose metabolic disorder. GSDIa patients are characterized by hypoglycemia, hepatomegaly, hyperlipidemia, and hyperlactacidemia. This retrospective study aimed to review the lipid status, explore lipid treatment targets, and assess preferable lipid-lowering drugs. PATIENTS AND METHODS: Clinical data on GSDIa patients' characteristics were collected. Most...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholesterol
Share to Glucose-6-Phosphatase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glycogen Storage Disease Type I

Share to Hyperlipidemias

Share to Hypolipidemic Agents

Share to Lipid Metabolism

Share to Starch

Share to Triglycerides

Source

Identifiers

PMID: 33090409
DOI: 10.26355/eurrev_202010_23218

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lipid status and linear relationship between total cholesterol and triglycerides in glycogen storage disease type I.PMID 33090409Read ↗

Glycogen storage disease type I: Genetic etiology, clinical manifestations, and conventional and gene therapiesSemantic proximity Read ↗

[Hepatic glycogen storage diseases: Symptoms, management and associated mutations].Semantic proximity Read ↗

Glycogen Storage Diseases: A Brief Review and Update on Clinical Features, Genetic Abnormalities, Pathologic Features, and TreatmentSemantic proximity Read ↗

Clinical Analysis and Long-term Treatment Monitoring of 3 Patients with Glycogen Storage Disease Type IbSemantic proximity Read ↗

Genotypic and clinical analysis of 49 Chinese children with hepatic glycogen storage diseases.Semantic proximity Read ↗

The role of autophagy in the pathogenesis of glycogen storage disease type II (GSDII)Semantic proximity Read ↗

[Advances on the management of renal lesion in glycogen storage disease type I].Semantic proximity Read ↗

Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia.Semantic proximity Read ↗

Glycogen storage diseases. Phenotypic, genetic, and biochemical characteristics, and therapy.Semantic proximity Read ↗

[Genetic and clinical characteristics of 26 cases with glycogen storage disease type Ⅲ].Semantic proximity Read ↗

Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)Semantic proximity Read ↗

Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.